Clinical trial has received regulatory approval and involves endometriosis candidate SN132D

Phase 3 clinical trial focuses on adults with moderate-to-severe chronic hand eczema

Partnership aims to progress personalised cancer therapy by incorporating doggybone DNA

Data reinforces potential to deliver new standards across HER2-targetable breast cancer

Implantable ARC therapy demonstrates potential to improve blood pressure regulation

Data supports LR 09 as a vital checkpoint inhibitor for treating leukaemia patients